Senna Use for Constipation Management

Clinical Guideline Recommendations

• The American Gastroenterological Association/American College of Gastroenterology guidelines suggest that longer-term use of senna is probably appropriate when medically necessary, although data are needed to better understand tolerance and side effects 1, 2, 3
• The National Comprehensive Cancer Network recommends senna 2-3 tablets 2-3 times daily with a goal of one non-forced bowel movement every 1-2 days, without specific duration limits, in palliative care settings with limited life expectancy 5
• Senna remains a recommended option as part of ongoing constipation management for patients with months to weeks of life expectancy 5

Safety and Efficacy Considerations

• The evidence base for senna consists primarily of short-term trials (4 weeks), creating uncertainty about extended use 4
• Senna is not recommended in pregnancy due to weak genotoxic effects observed in animal studies with chemically similar substances 4
• Be aware that 83% of participants in clinical trials reduced their senna dose during the study period, suggesting dose-related tolerability issues 4

Treatment Escalation

• If senna fails to provide adequate relief after appropriate trial and medical evaluation, consider escalation to prescription agents such as lubiprostone, linaclotide, plecanatide, or prucalopride 1, 2, 3